Published in Arch Intern Med on September 10, 2007
Refilling and switching of antiepileptic drugs and seizure-related events. Clin Pharmacol Ther (2010) 2.31
Helping patients simplify and safely use complex prescription regimens. Arch Intern Med (2011) 2.29
Variability in pharmacy interpretations of physician prescriptions. Med Care (2009) 2.18
The legibility of prescription medication labelling in Canada: Moving from pharmacy-centred to patient-centred labels. Can Pharm J (Ott) (2014) 1.47
Effect of standardized, patient-centered label instructions to improve comprehension of prescription drug use. Med Care (2011) 1.47
Usability of FDA-approved medication guides. J Gen Intern Med (2012) 1.20
A Patient-Centered Prescription Drug Label to Promote Appropriate Medication Use and Adherence. J Gen Intern Med (2016) 0.98
An evaluation of the relationship between the implementation of a newly designed prescription drug label at Target pharmacies and health outcomes. Med Care (2009) 0.97
Impact of generic substitution decision support on electronic prescribing behavior. J Am Med Inform Assoc (2010) 0.94
Can improved prescription medication labeling influence adherence to chronic medications? An evaluation of the Target pharmacy label. J Gen Intern Med (2009) 0.93
Expanding the Universal Medication Schedule: a patient-centred approach. BMJ Open (2014) 0.88
What's in a label? An exploratory study of patient-centered drug instructions. Eur J Clin Pharmacol (2011) 0.85
Development of a patient-centered bilingual prescription drug label. J Health Commun (2013) 0.85
Medication adherence: helping patients take their medicines as directed. Public Health Rep (2012) 0.84
Current practices for labeling medications in hospitals in Riyadh, Saudi Arabia. Saudi Pharm J (2013) 0.81
Prescription drug labeling medication errors: a big deal for pharmacists. J Young Pharm (2010) 0.80
Practical strategies to improve communication with patients. P T (2011) 0.77
A randomized, controlled study of an educational intervention to improve recall of auxiliary medication labeling and adherence to antibiotics. SAGE Open Med (2013) 0.77
ClereMed: Lessons Learned From a Pilot Study of a Mobile Screening Tool to Identify and Support Adults Who Have Difficulty With Medication Labels. JMIR Mhealth Uhealth (2014) 0.75
The electronic medication complete communication (EMC(2)) study: Rationale and methods for a randomized controlled trial of a strategy to promote medication safety in ambulatory care. Contemp Clin Trials (2016) 0.75
Refining Prescription Warning Labels Using Patient Feedback: A Qualitative Study. PLoS One (2016) 0.75
Improving pediatric liquid medication labeling of the hospital information system in Malaysia: qualitative analysis of pharmacists' perceptions. Pharm Pract (Granada) (2016) 0.75
Improving accuracy of medication identification in an older population using a medication bottle color symbol label system. BMC Fam Pract (2011) 0.75
PictureRx: Illustrated medication instructions for patients with limited health literacy. J Am Pharm Assoc (2003) (2012) 0.75
Unnecessary complexity of home medication regimens among seniors. Patient Educ Couns (2014) 0.75
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev (2015) 11.05
Variable selection for propensity score models. Am J Epidemiol (2006) 10.68
Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med (2007) 9.88
A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol (2005) 8.77
Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med (2005) 8.44
Literacy and misunderstanding prescription drug labels. Ann Intern Med (2006) 7.85
Meta-analysis: chronic disease self-management programs for older adults. Ann Intern Med (2005) 7.73
An open letter to The BMJ editors on qualitative research. BMJ (2016) 7.49
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (2009) 7.40
A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol (2005) 7.31
Long-term persistence in use of statin therapy in elderly patients. JAMA (2002) 7.19
Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample. Ann Intern Med (2004) 6.86
Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA (2008) 6.63
Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J (2004) 6.57
Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians. Ann Intern Med (2013) 6.07
A randomized study of how physicians interpret research funding disclosures. N Engl J Med (2012) 5.47
Health literacy and mortality among elderly persons. Arch Intern Med (2007) 5.14
Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med (2014) 4.99
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol (2003) 4.95
Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2011) 4.78
Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med (2004) 4.68
Full coverage for preventive medications after myocardial infarction. N Engl J Med (2011) 4.51
The causal pathways linking health literacy to health outcomes. Am J Health Behav (2007) 4.49
Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med (2012) 4.47
New FDA breakthrough-drug category--implications for patients. N Engl J Med (2014) 4.30
Screening for HIV in health care settings: a guidance statement from the American College of Physicians and HIV Medicine Association. Ann Intern Med (2008) 4.28
Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst (2002) 4.16
Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization. Ann Intern Med (2003) 4.15
Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med (2006) 4.01
A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol (2011) 3.98
Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA (2010) 3.85
Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol (2007) 3.82
The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med (2010) 3.78
Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch Intern Med (2006) 3.75
Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2012) 3.74
The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med (2006) 3.64
Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case-control studies. Ann Intern Med (2014) 3.62
Rethinking global access to vaccines. BMJ (2008) 3.60
Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2011) 3.58
The 21st Century Cures Act--Will It Take Us Back in Time? N Engl J Med (2015) 3.52
New contract for general practitioners. BMJ (2003) 3.45
Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison. BMJ (2013) 3.43
The quality of pharmacologic care for vulnerable older patients. Ann Intern Med (2004) 3.34
Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol (2005) 3.33
Online social networking by patients with diabetes: a qualitative evaluation of communication with Facebook. J Gen Intern Med (2010) 3.31
The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med (2011) 3.27
The medical device excise tax--over before it begins? N Engl J Med (2013) 3.25
Rethinking the use of physicians as hired expert lecturers. Ann Intern Med (2014) 3.22
Drug-review deadlines and safety problems. N Engl J Med (2008) 3.16
Variations in pill appearance of antiepileptic drugs and the risk of nonadherence. JAMA Intern Med (2013) 3.13
Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation (2009) 3.09
Balancing innovation, access, and profits--market exclusivity for biologics. N Engl J Med (2009) 3.08
Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum (2006) 3.04
Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS (2006) 3.02
Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation (2004) 2.98
University-based science and biotechnology products: defining the boundaries of intellectual property. JAMA (2005) 2.95
A consensus approach toward the standardization of back pain definitions for use in prevalence studies. Spine (Phila Pa 1976) (2008) 2.94
Compliance with osteoporosis medications. Arch Intern Med (2005) 2.91
Will this patient develop persistent disabling low back pain? JAMA (2010) 2.87
Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med (2002) 2.85
Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. Arch Intern Med (2002) 2.82
Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol (2006) 2.81
Self reported receipt of care consistent with 32 quality indicators: national population survey of adults aged 50 or more in England. BMJ (2008) 2.80
High-cost generic drugs--implications for patients and policymakers. N Engl J Med (2014) 2.79
Internet marketing of herbal products. JAMA (2003) 2.77
Economic implications of evidence-based prescribing for hypertension: can better care cost less? JAMA (2004) 2.77
Diagnosis of obstructive sleep apnea in adults: a clinical practice guideline from theAmerican College of Physicians. Ann Intern Med (2014) 2.75
Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. Am J Epidemiol (2010) 2.74
Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA (2010) 2.71
High-value, cost-conscious health care: concepts for clinicians to evaluate the benefits, harms, and costs of medical interventions. Ann Intern Med (2011) 2.70
Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2008) 2.69
Sending pharma better signals. Science (2005) 2.69
Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med (2007) 2.69
Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis (2005) 2.65
Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res (2003) 2.65
Characteristics of clinical trials to support approval of orphan vs nonorphan drugs for cancer. JAMA (2011) 2.60
Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol (2008) 2.58
Performance of propensity score calibration--a simulation study. Am J Epidemiol (2007) 2.56
Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. Am J Epidemiol (2005) 2.55
A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. J Rheumatol (2002) 2.54
Patients' perceptions of generic medications. Health Aff (Millwood) (2009) 2.54
Practical, legal, and ethical issues in expanded access to investigational drugs. N Engl J Med (2015) 2.53
Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors. N Engl J Med (2004) 2.52
Health literacy: an overlooked factor in understanding HIV health disparities. Am J Prev Med (2007) 2.51
Low back pain. J Orthop Sports Phys Ther (2012) 2.50
Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med (2012) 2.47
Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation (2008) 2.42
Improving patient understanding of prescription drug label instructions. J Gen Intern Med (2008) 2.39
Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction. Epidemiology (2005) 2.38